StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.32−0.33 (-9.04%)

Close on Nov 20, 2026Market cap $477.72MP/E 22.6Yield –

Anbio Biotechnology free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Anbio Biotechnology

Anbio Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Anbio Biotechnology figures

See a number that looks wrong?